Clinuvel Pharmaceuticals Limited (CUV.AX) Dividend Yield, History & Forecast

Clinuvel Pharmaceuticals Limited (CUV.AX) is a Biotechnology company in the Healthcare sector listed on the Australian Securities Exchange. It pays a current dividend yield of 0.50% ($0.05 per share annually (TTM)). The trailing twelve-month payout ratio is 7.7%; the market capitalization is approximately $504M.

Loading quote...

Frequently Asked Questions about Clinuvel Pharmaceuticals Limited (CUV.AX)

What is Clinuvel Pharmaceuticals Limited's dividend yield?
Clinuvel Pharmaceuticals Limited (CUV.AX) pays a current trailing twelve-month dividend yield of 0.50%, which works out to $0.05 per share annually based on the most recent payout schedule.
Is Clinuvel Pharmaceuticals Limited a Dividend Aristocrat?
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is Clinuvel Pharmaceuticals Limited in?
Clinuvel Pharmaceuticals Limited (CUV.AX) operates in the Healthcare sector, specifically the Biotechnology industry.
What is Clinuvel Pharmaceuticals Limited's dividend payout ratio?
Clinuvel Pharmaceuticals Limited (CUV.AX)'s trailing twelve-month dividend payout ratio is 7.7%. The payout ratio measures what percentage of earnings is paid out as dividends — a lower ratio generally suggests a more sustainable dividend.
Clinuvel Pharmaceuticals Limited (CUV.AX) Dividend Yield, History & Forecast | Dividend Wealth